Stocklytics Platform
Asset logo for symbol PLSE
Pulse Biosciences
PLSE62
$17.37arrow_drop_down3.39%-$0.60
Asset logo for symbol PLSE
PLSE62

$17.37

arrow_drop_down3.39%

Performance History

Chart placeholder
Key Stats
Open$17.86
Prev. Close$17.98
EPS-0.82
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range17.18
18.40
52 Week Range3.78
22.69
Ratios
Revenue-
EBITDA Margin %-
EPS-0.82

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Pulse Biosciences (PLSE)

Pulse Biosciences Inc (PLSE) is a medical technology company that specializes in the development and commercialization of advanced bioelectric therapies. The company's innovative platform, known as Nano-Pulse Stimulation (NPS), harnesses the power of nanosecond duration pulsed electric fields to selectively destroy cells while preserving surrounding healthy tissue. This technology has wide-ranging applications in dermatology, oncology, and other medical fields. PLSE's goal is to transform the treatment of challenging diseases and conditions through the use of its proprietary NPS platform.
As of the latest quote, Pulse Biosciences Inc (PLSE) is trading at $16.45 per share. The stock has experienced significant volatility in recent months, with a 52-week range of $9.20 to $27.55. However, it is important to note that past performance is not indicative of future results. Investors should conduct thorough research and analysis before making any investment decisions.
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Headquarters
Hayward
Employees
61
Exchange
NASDAQ
add Pulse Biosciences  to watchlist

Keep an eye on Pulse Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Pulse Biosciences 's (PLSE) price per share?

The current price per share for Pulse Biosciences (PLSE) is $17.4. The stock has seen a price change of -$0.58 recently, indicating a -3.23% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Pulse Biosciences (PLSE)?

For Pulse Biosciences (PLSE), the 52-week high is $22.69, which is 30.4% from the current price. The 52-week low is $3.78, the current price is 360.32% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Pulse Biosciences (PLSE) a growth stock?

Pulse Biosciences (PLSE) has shown an average price growth of -5.18% over the past three years. It has received a score of 93 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pulse Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Pulse Biosciences (PLSE) stock price performance year to date (YTD)?

As of the latest data, Pulse Biosciences (PLSE) has a year-to-date price change of 57.89%. Over the past month, the stock has experienced a price change of -1.58%. Over the last three months, the change has been 0.46%. Over the past six months, the figure is 64.46%. Looking at a longer horizon, the five-year price change stands at 30.63%.
help

Is Pulse Biosciences (PLSE) a profitable company?

Pulse Biosciences (PLSE) has a net income of -$42.21M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$43.57M. Furthermore, the EBITDA is -$47.33M.
help

What is the market capitalization of Pulse Biosciences (PLSE)?

Pulse Biosciences (PLSE) has a market capitalization of $1.07B. The average daily trading volume is 17.48, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level